| RS1553541206 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553541218 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553541303 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553541329 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1553541464 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1553541473 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553541517 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553542017 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1553542142 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553542199 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553542262 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1553542309 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553542378 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553542421 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1553542669 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553542686 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553542773 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553543148 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553543215 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553543316 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553543340 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553543413 |
TTN
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1553543506 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553543824 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553543828 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553543921 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1553544064 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553544102 |
SATB2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553544133 |
SATB2
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS1553544158 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1553544187 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1553544470 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553544559 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553544579 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553544667 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1553544821 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553545126 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553545522 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553545567 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553545660 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553545704 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Generalized epilepsy with febrile seizures plus |
| RS1553545740 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553545742 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553545923 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS1553546045 |
PTH2R
|
Health Risk |
Likely pathogenic |
Syndromic intellectual disability, Syndromic intellectual disability |
| RS1553546495 |
ABCB11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553546668 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS1553546728 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553546763 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553546789 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553546836 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant epilepsy, Inborn genetic diseases |
| RS1553546975 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1553546981 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553547055 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1553547380 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553547403 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553547448 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Severe myoclonic epilepsy in infancy |
| RS1553547454 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553547528 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553547657 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553547838 |
SATB2
|
Health Risk |
Pathogenic |
Isolated cleft palate, Dystonic disorder |
| RS1553547885 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553547906 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553548018 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553548063 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553548096 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553548181 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553548194 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Obesity, Seizure |
| RS1553548207 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553548393 |
NHEJ1
|
Health Risk |
Pathogenic |
— |
| RS1553548666 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553548752 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553548771 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553549333 |
FARSB
|
Health Risk |
Pathogenic |
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency, Rajab interstitial lung disease with brain calcifications |
| RS1553549450 |
SCN1A
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS1553549461 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553549471 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1553549483 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553549500 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553549660 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Generalized epilepsy with febrile seizures plus |
| RS1553549667 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS1553549679 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553549717 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553549834 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553549845 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553549902 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553549997 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553550552 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553550574 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553550618 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553550625 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553551006 |
DYSF
|
Health Risk |
Pathogenic |
Absent muscle fiber dysferlin, Foot dorsiflexor weakness |
| RS1553551304 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553551312 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553551314 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553551361 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy 6B |
| RS1553551385 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 6B, Early-infantile DEE |
| RS1553551425 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553551463 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553551483 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |